As of Wednesday close, Science 37 Holdings Inc.’s (NASDAQ:SNCE) stock was down -$0.03, moving down -8.52 percent to $0.30. The average number of shares traded per day over the past five days has been 9,223,899 shares. 1 time new highs have been achieved over the past 5 days, with a -$0.1099 fall in that time frame. In the last twenty days, the average volume was 3,961,715, while in the previous 50 days, it was 1,966,392.
Since last month, SNCE stock rose 36.02%. Shares of the company fell to $0.2100 on 07/18/23, the lowest level in the past month. A 52-week high of $2.07 was reached on 02/02/23 after having rallying from a 52-week low of $0.19. Since the beginning of this year, SNCE’s stock price has dropped by -26.78% or -$0.1112, and marked a new high 8 times. However, the stock has declined by -85.31% since its 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
SNCE stock investors should be aware that Science 37 Holdings Inc. (SNCE) stock had its last reported insider trading activity 273 days ago on Nov 17. Pellizzari Christine A, the Chief Legal Officer of the company, purchased of 5,000 shares for $0.81 on Nov 17. It resulted in a $4,032 investment by the insider.
Valuation Metrics
The stock’s beta is 1.10. Besides these, the trailing price-to-sales (P/S) ratio of 0.77, the price-to-book (PB) ratio of 0.57.
Financial Health
In the three months ended June 29, Science 37 Holdings Inc.’s quick ratio stood at 4.60, while its current ratio was 4.60, showing that the company is able to pay off its debt. On the profitability front, the trailing twelve-month gross margin is 26.10% percent. Based on annual data, SNCE earned $15.87 million in gross profit and brought in $70.15 million in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was -156.00%. Return on equity (ROE) for the past 12 months was -135.50%.
According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. SNCE’s revenue rose 100.0% to $18.69 million during the quarter, while net income inched up to $19.28 million. While analysts expected Science 37 Holdings Inc. to report -$0.12 quarterly earnings, the actual figure was -$0.07 per share, beating the consensus estimate by 41.70%. During the quarter, the company generated -$20.26 million in EBITDA. The liabilities of Science 37 Holdings Inc. were 24.71 million at the end of its most recent quarter ended June 29, and its total debt was $1.03 million. The value of shareholders’ equity is $117.11 million.
Technical Picture
This quick technical analysis looks at Science 37 Holdings Inc.’s (SNCE) price momentum. With a historical volatility rate of 353.38%, the RSI 9-day stood at 46.92% on 16 August.
With respect to its five-day moving average, the current Science 37 Holdings Inc. price is down by -26.55% percent or -$0.1099. At present, SNCE shares trade +28.32% above its 20-day simple moving average and +0.23% percent above its 100-day simple moving average. However, the stock is currently trading approximately +8.57% above its SMA50 and -79.03% below its SMA200.
Stochastic coefficient K was 22.76% and Stochastic coefficient D was 37.08%, while ATR was 0.0782. Given the Stochastic reading of 15.97% for the 14-day period, the RSI (14) reading has been calculated as 49.49%. As of today, the MACD Oscillator reading stands at -0.0310.
Analyst Ratings
Science 37 Holdings Inc. (SNCE) has been rated Overweight by analysts. According to 0 brokerage firms, SNCE is a sell, and 1 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 1 analyst rate Science 37 Holdings Inc. stock as buy, with 3 recommending it as overweight.
With a median target price of $2.00, the current consensus forecast for the stock is $1.00 – $2.50. Based on these forecasts, analysts predict Science 37 Holdings Inc. (SNCE) will achieve an average price target of $1.88.
